Skip to main content
SpringerLink
Log in

Cardiovascular Changes of the Perimenopause and Menopause

  • Chapter
Perimenopause

Part of the book series: Serono Symposia USA ((SERONOSYMP))

  • 107 Accesses

Abstract

The menopause is defined as the permanent cessation of menstruation resulting from loss of ovarian function. The time period preceding the menopause during which ovarian function changes from regular to irregular menstrual cyclicity is termed the climacteric and sometimes perimenopause. The mean age for menopause is approximately 51.5 years with a range of approximately 45 to 55 (1). Unlike the age of menarche, which is highly dependent on body mass, the age of menopause appears genetically predetermined. There is no current evidence that race, socioeconomic status, or ages at menarche or pregnancy affect the age at menopause (1), although this question has not yet been carefully explored. Menopausal age has increased over the past century from 40 to 50 years of age (1). As the mean life expectancy for a woman is 78 years, more than one third of a woman’s life will be spent after menopause.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mishell D, Davajan V, Lobo R. Infertility, contraception and reproductive endocrinology, 3rd ed. Boston, MA: Blackwell Scientific, 1991.

    Google Scholar 

  2. Speroff L, Glass R, Kase N, eds. Clinical gynecologic endocrinology and infertility, 5th ed. Baltimore: Williams & Wilkins, 1994:583–613.

    Google Scholar 

  3. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev 1993;73(4):725–56.

    PubMed  CAS  Google Scholar 

  4. Fleg, JL. Alterations in cardiovascular structure and function with advancing age. Am J Cardiol 1986;57:33–44.

    Article  Google Scholar 

  5. Docherty JR. Cardiovascular responses in aging. Pharmacol Rev 1990; 42:103–26.

    PubMed  CAS  Google Scholar 

  6. Davies MJ. Pathology of the conducting system. In: Caird FI, Dall JC, Kennedy RD, eds. Cardiology in old age. New York: Plenum Press, 1976.

    Google Scholar 

  7. Tuttle RS. Age-related changes in the sensitivity of rat aortic strips to norepinephrine and associated chemical and structural alterations. J Gerontol 1966;21:510–16.

    PubMed  CAS  Google Scholar 

  8. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1980;61:1179–82.

    PubMed  CAS  Google Scholar 

  9. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity and risks of stroke: the Framingham study. JAMA 1981;245:1225–9.

    Article  PubMed  CAS  Google Scholar 

  10. Landahl S, Bengtsson C, Sigurdsson JA, Svanborg A, Svardsuddok K. Age-related changes in blood pressure. Hypertension 1986;8:1044–9.

    PubMed  CAS  Google Scholar 

  11. United States Bureau of Census (1986). Table no. 114. Death rates, 1960–1983, and deaths 1960–1983, from selected causes. Statistical Abstract of the United States. Washington, DC: U.S. Government Printing Office, 1987:75.

    Google Scholar 

  12. Harlan WR. Cardiovascular disease care for women: service utilization, disability, and costs from the National Medical Care Utilization and Expenditure Survey. In: Eaker ED, Packard B, Wenger N, Clarkson T, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:55–61.

    Google Scholar 

  13. Kalin M, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990;55(8):330–52.

    Article  PubMed  CAS  Google Scholar 

  14. McGill HC, Stern MP. Sex and atherosclerosis. Atherosclerosis Rev 1979; 4:157–242.

    Google Scholar 

  15. Weiss NS. Relationship of menopause to serum cholesterol and arterial blood pressure: the United States health examination survey of adults. Am J Epidemiol 1972;96:237–41.

    Google Scholar 

  16. Markovitz JH, Matthews KA, Wing RR, Kuller LH, Meilahn EN. Psychological, biological and health behavior predictors of blood pressure changes in middle-aged women. J Hypertens 1991;9(5):399–400.

    Article  PubMed  CAS  Google Scholar 

  17. Van Berestyn EC, Van Hof MA, De Waard H. Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study. Am J Epidemiol 1989;129:947–55.

    Google Scholar 

  18. Taylor RD, Corcoran AC, Page I. Menopausal hypertension: a critical study. Am J Med Sci 1947;213:475–6.

    Article  PubMed  CAS  Google Scholar 

  19. Eskin BA. Menopause and cardiovascular disease. In: Eskin BA, ed. The menopause: comprehensive management, 3rd ed. New York: McGraw-Hill, 1992:117–35.

    Google Scholar 

  20. Romm PA, Green CE, Reagan K, Rackley CE. Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991;67:479–83.

    Article  PubMed  CAS  Google Scholar 

  21. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. Ann Intern Med 1979;90:85–91.

    PubMed  CAS  Google Scholar 

  22. Kannel WB, Gordon T. Cardiovascular effects of the menopause. In: Mishell D, ed. Menopause: physiology and pharmacology. Chicago: Year Book Medical, 1987:91–102.

    Google Scholar 

  23. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992;85(307–308);889–96.

    PubMed  CAS  Google Scholar 

  24. Neaton JD, Jullr LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 1984;108:759–69.

    Article  PubMed  CAS  Google Scholar 

  25. Notelovitz M, Gudat JC, Ware MD, Dougherty MC. Lipids and lipoproteins in women after oophorectomy and the response to estrogen therapy. Br J Obstet Gynaecol 1983;90(2): 171–7.

    Article  PubMed  CAS  Google Scholar 

  26. Bass KM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular deaths in women. Circulation 1993;153:2209.

    Google Scholar 

  27. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85:447–52.

    PubMed  CAS  Google Scholar 

  28. Longcope C, Herbert PN, McKinlay SM, Goldfield SR. The relationship of total and free estrogens and sex-hormone binding globulin with lipoproteins in women. J Clin Endocrinol Metab 1990;71:67–72.

    Article  PubMed  CAS  Google Scholar 

  29. Sitruk-Ware R. Cardiovascular risk at the menopause — role of sexual steroids. Horm Res 1995;43:58–63.

    Article  PubMed  CAS  Google Scholar 

  30. Robinson RW, Higano N, Cohen W. Increased incidence of coronary heart disease in women castrated prior to menopause. Arch Intern Med 1959; 104:908–13.

    PubMed  CAS  Google Scholar 

  31. Matthews K, Wing RR, Kuller LH, Meilahn EN, Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle aged healthy women. Arch Intern Med 1994;154:2349–55.

    Article  PubMed  CAS  Google Scholar 

  32. Campos H, McNamara JR, Wilson PW, Ordoras JM, Schaefer EJ. Differences in low-density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metabol 1988; 67(1):30–5.

    Article  CAS  Google Scholar 

  33. Clarkson TB, Adams MR, Kaplan JR, Shively CA, Koritnik DR. From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. Am J Obstet Gynecol. 1989;160(5, Pt 2);1280–5.

    PubMed  CAS  Google Scholar 

  34. Witteman JCM, Grobbee D, Kok F, Hofman A, Valkenburgh H. Increased risk of atherosclerosis in women after the menopause. Br Med J 1989; 298:642–664.

    Article  CAS  Google Scholar 

  35. Salonen JT. The role of iron as a cardiovascular risk factor. Curr Opin Lipidol 1993;4:277–82.

    Article  CAS  Google Scholar 

  36. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 1978;89:157–61.

    PubMed  CAS  Google Scholar 

  37. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1:1293–4.

    Article  PubMed  CAS  Google Scholar 

  38. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86:803–11.

    PubMed  CAS  Google Scholar 

  39. Berge LN, Bonaa KH, Nordoy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arterioscler Thromb 1994; 14:(6)857–61.

    Article  PubMed  CAS  Google Scholar 

  40. Kannel WB, Gordon T. Obesity and cardiovascular disease: the Framingham study. In: Burland WL, Samuel P, Yudkin J, eds. Obesity symposium. New York: Churchill Livingstone, 1974:24–51.

    Google Scholar 

  41. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham study. Am J Epidemiol 1976;103:304–11.

    PubMed  CAS  Google Scholar 

  42. Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B. Cigarette smoking, relative weight and menopause. Am J Epidemiol 1983; 117(6):651–8.

    PubMed  CAS  Google Scholar 

  43. Wing RR, Matthews KA, Kuller LH, Meilahn En, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97–102.

    Article  PubMed  CAS  Google Scholar 

  44. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity and risk for cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 1984;288:1401–4.

    Article  CAS  Google Scholar 

  45. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984;289:1257–61.

    Article  CAS  Google Scholar 

  46. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd JR. Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? Am J Epidemiol 1992;135:266–73.

    PubMed  CAS  Google Scholar 

  47. Ostlund RE Jr, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin levels and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990;322(4):229–34.

    Article  PubMed  Google Scholar 

  48. Ebeling P, Koivisto V. Physiological importance of dehydroepiandrosten-dione. Lancet 1994;343:1479–81.

    Article  PubMed  CAS  Google Scholar 

  49. Mortola JF, Yen SS. The effects of oral dehydroepiandrostendione on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab 1990;71:696–704.

    Article  PubMed  CAS  Google Scholar 

  50. Barrett-Connor E, Khaw K. Absence of an inverse relation of dehydroepiandrostendione sulfate with cardiovascular mortality in postmenopausal women. N Engl J Med 1986;315:1519–24.

    Article  PubMed  CAS  Google Scholar 

  51. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham study. JAMA 1988;260(23):3456–60.

    Article  PubMed  CAS  Google Scholar 

  52. De Pirro R, Fusco A, Bertoli A, Greco AV, Lauro R. Insulin receptors during the menstrual cycle in normal women. J Clin Endocrinol Metab 1978; 47:1387–9.

    Article  PubMed  Google Scholar 

  53. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131–41.

    Article  PubMed  CAS  Google Scholar 

  54. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabeto-logia 1980;19(3):205–10.

    Article  CAS  Google Scholar 

  55. Khaw K, Barrett-Connor E. Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin Sci 1991;80:199–203.

    PubMed  CAS  Google Scholar 

  56. Preziosi P, Barrett-Connor E, Papoz L, et al. Interrelationship between plasma sex hormone binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab 1993;76:283–7.

    Article  PubMed  CAS  Google Scholar 

  57. Gebara O, Mittleman M, Sutherland P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study. Circulation 1995;91:1952–8.

    PubMed  CAS  Google Scholar 

  58. Prins MH, Hirsh J. A critical review of the relationship between impaired fibrinolysis and myocardial infarction. Am Heart J 1991;122:545–51.

    Article  PubMed  CAS  Google Scholar 

  59. Juhan-Vague I, Collen D. On the role of coagulation and fibrinolysis in atherosclerosis. Ann Epidemiol 1992;2:427–38.

    Article  PubMed  CAS  Google Scholar 

  60. Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA 1987;258:1183–6.

    Article  PubMed  CAS  Google Scholar 

  61. Notelovitz M, Kitchens CS, Rappaport V, Coone L, Dougherty M. Menopausal status associated with increased inhibition of blood coagulation. Am J Obstet Gynecol 1981;141(2):149–52.

    PubMed  CAS  Google Scholar 

  62. Stangel JJ, Innerfield I, Reyniak JV, Stone ML. The effect of conjugated estrogens on coagulability in menopausal women. Obstet Gynecol 1977; 49:314–6.

    PubMed  CAS  Google Scholar 

  63. Notelovitz M, Kitchens C, Ware M, Hirschberg K, Coone L. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation. Obstet Gynecol 1982;62(5):596–600.

    Google Scholar 

  64. La Rosa JC. Metabolic effects of estrogens and progestins. Fertil Steril 1994;62(Suppl 2):140S–6S.

    Google Scholar 

  65. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Henneckens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction (comment). Lancet 1993;341:1165–8.

    Article  PubMed  CAS  Google Scholar 

  66. Hamsten A, de Faire V, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987;2:3–9.

    Article  PubMed  CAS  Google Scholar 

  67. Bush TL, Barrett Connor E. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:80–104.

    Google Scholar 

  68. Hemminski E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogens among middle-aged Massachusetts women. DICP Ann Pharmacother 1991; 25:418–23.

    Google Scholar 

  69. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA 1989;261(14):2095–100.

    Article  PubMed  CAS  Google Scholar 

  70. Grady D, Rubin SM, Petitti DM, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117:1016–37.

    PubMed  CAS  Google Scholar 

  71. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47–63.

    Article  PubMed  CAS  Google Scholar 

  72. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75–8.

    Article  PubMed  CAS  Google Scholar 

  73. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet 1981;1:858–60.

    Article  PubMed  CAS  Google Scholar 

  74. Stampfer MJ, Colditz GA, Willett HC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. N Engl J Med 1991;325:756.

    Article  PubMed  CAS  Google Scholar 

  75. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined homogeneous community. Am J Epidemiol 1988; 128:606–14.

    PubMed  CAS  Google Scholar 

  76. Burch JC, Byrd BF Jr, Vaughn WK. The effects of long-term estrogen on hysterectomized women. Am J Obstet Gynecol 1974;118:778–82.

    PubMed  CAS  Google Scholar 

  77. Chopra IJ, Tulchinsky D, Greenway FL. Estrogen-androgen imbalance in hepatic cirrhosis. Ann Intern Med 1973;79:198–203.

    PubMed  CAS  Google Scholar 

  78. Horton R, Neisler J. Plasma androgens in patients with the polycystic ovary syndrome. J Clin Endocrinol Metab 1968;28:479–84.

    Article  PubMed  CAS  Google Scholar 

  79. Nabulsi AA, Foison AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069–75.

    Article  PubMed  CAS  Google Scholar 

  80. Scanu AM, ed. Lipoprotein (a). New York: Academic Press, 1990.

    Google Scholar 

  81. Windier E, Kovanen P, Chao YS, Brown M, Havel R, Goldsein J. The estradiol-stimulated lipoprotein receptor of rat liver. J Biol Chem 1980; 255(21): 10464–71.

    Google Scholar 

  82. Granfone A, Campos H, McNamara JR, et al. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism 1992;41:1193–8.

    Article  PubMed  CAS  Google Scholar 

  83. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement therapy on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196–204.

    Article  PubMed  CAS  Google Scholar 

  84. Tikkanen MJ, Kuusi T, Nikkila EA, Sipinen S. Postmenopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins: a review. Maturitas 1986;8(1):7–17.

    Article  PubMed  CAS  Google Scholar 

  85. Egeland GM, Kuller LH, Matthews KA, Kelsey SF, Cauley J, Guzick D. Hormone replacement therapy and lipoprotein changes during early menopause. Obstet Gynecol 1990;76:776.

    Article  PubMed  CAS  Google Scholar 

  86. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989;79(1):8–15.

    Article  PubMed  CAS  Google Scholar 

  87. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics’ Program Follow-Up Study. Circulation 1987;75(6):1002–9.

    Article  Google Scholar 

  88. Ross R. Factors influencing atherogenesis. In: Hurst JW, ed. The heart. New York: McGraw-Hill, 1986:801–6.

    Google Scholar 

  89. Sullivan JM, Vander Z, Waag R, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108(3):358–63.

    PubMed  CAS  Google Scholar 

  90. McFarland KF, Boniface NE, Harnung CA, Earnhardt W, Humphries JO. Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J 1989;117(6):1209–14.

    Article  PubMed  CAS  Google Scholar 

  91. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69:176–8.

    Article  PubMed  CAS  Google Scholar 

  92. Falkeborn M, Persson I, Adami HO, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992;99:821–8.

    Article  PubMed  CAS  Google Scholar 

  93. Lantta M, Karkkainen J, Lehtovirta P. Progesterone and estradiol receptors in the cytosol of the human uterine artery. Am J Obstet Gynecol 1983;147:627–33..

    PubMed  CAS  Google Scholar 

  94. Wagner ID, Clarkson TB, St. Clair RV, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 1991;88:1995–2002.

    Article  PubMed  CAS  Google Scholar 

  95. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452–7.

    Article  PubMed  CAS  Google Scholar 

  96. Adams MR. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril 1987;47(6): 1010–8.

    PubMed  CAS  Google Scholar 

  97. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81:1680–7.

    Article  PubMed  CAS  Google Scholar 

  98. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992;89:11259–63

    Article  PubMed  CAS  Google Scholar 

  99. Stumpf WE, Sar M, Aumuller G. The heart: a target organ for estradiol. Science 1977; 196:319–20.

    Article  PubMed  CAS  Google Scholar 

  100. Klangkalya B, Chan A. The effects of ovarian hormones on beta-adrenergic and muscarinic receptors in rat heart. Life Sci 1988;42:2307–14.

    Article  PubMed  CAS  Google Scholar 

  101. Barrett-Connor E, Wilcosky T, Wallace RB, Heiss G. Resting and exercise electrocardiographic abnormalities associated with sex hormone use in women. Am J Epidemiol 1986;123(1):81–8.

    PubMed  CAS  Google Scholar 

  102. Pines A, Fisman EZ, Levo Y, et al. The effects of hormone replacement therapy in normal postmenopausal women: measurement of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 1991;164:806–12.

    PubMed  CAS  Google Scholar 

  103. Pines A, Fisman EZ, Levo Y, et al. Menopause induced changes in left ventricular wall thickness. Am J Cardiol 1993;72:240–1.

    Article  PubMed  CAS  Google Scholar 

  104. Veille JC, Morton MJ, Burry K, Nemeth M, Speroff L. Estradiol and hemodynamics during ovulation induction. J Clin Endocrinol Metab 1986; 63(3):721–4.

    Article  PubMed  CAS  Google Scholar 

  105. Lehtovirta P. Haemodynamic effects of combined oestrogen-progestogen oral contraceptives. Br J Obstet Gynaecol 1974;81:517–25.

    Article  CAS  Google Scholar 

  106. Longo LD. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologie control. Am J Physiol 1983;245:R720–9.

    PubMed  CAS  Google Scholar 

  107. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533–7.

    Article  PubMed  CAS  Google Scholar 

  108. Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 1993;81:261–4.

    PubMed  CAS  Google Scholar 

  109. Thompson SG, Meade TW, Greenberg G. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. J Epidemiol Commun Health 1989;43(2):173–8.

    Article  CAS  Google Scholar 

  110. Sitruk-Ware R. Do estrogens protect against cardiovascular disease? In: Sitruk-Ware R, Utian WH, eds. The menopause and hormone replacement therapy. Facts and controversies. New York: Dekker, 1991:161–79.

    Google Scholar 

  111. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 1987;76(4):753–8.

    Article  PubMed  CAS  Google Scholar 

  112. Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biologie effects of transdermal estradiol. N Engl J Med 1986;314:1615–20.

    Article  PubMed  CAS  Google Scholar 

  113. Barrett-Connor E, Laakso M. Ischemic heart disease risk in postmenopausal women: effects of estrogen user on glucose and insulin levels. Arteriosclerosis 1990;10:531–4.

    Article  PubMed  CAS  Google Scholar 

  114. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol 1979;133:525–36.

    PubMed  CAS  Google Scholar 

  115. Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB. Effects of low doses of transdermal 17-ß estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 1992;74:1396–400.

    Article  PubMed  CAS  Google Scholar 

  116. Haarbo J, Marslew V, Golfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:323–6.

    Article  Google Scholar 

  117. Lindheim SR, Presser SC, Ditkoff EC, Vijod MA, Stanczyk FZ, Lobo RA. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil Steril 1993; 60:664–7.

    PubMed  CAS  Google Scholar 

  118. Centers for Disease Control. Coronary heart disease attributable to sedentary lifestyle-selected states, 1988. JAMA 1990;264:1390–2.

    Article  Google Scholar 

  119. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161–78.

    PubMed  Google Scholar 

  120. Salonen JT, Puska P, Tuomilehto J. Physical activity and risk of myocardial infarction, cerebral stroke and death. Am J Epidemiol 1983;115(4):526–37.

    Google Scholar 

  121. Leon AS, Connett J, Jacobs DR Jr, Rauramaa R. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. JAMA 1987;258(17):2388–95.

    Article  PubMed  CAS  Google Scholar 

  122. Goldberg L, Elliot DL, Schutz RW, Kloster FE. Changes in lipid and lipoprotein levels after weight training. JAMA 1984;252(4):504–6.

    Article  PubMed  CAS  Google Scholar 

  123. Lennon DLF. Total cholesterol and HDL-cholesterol changes during acute, moderate-intensity exercise in men and women. Metabolism 1983;32:244–9.

    Article  PubMed  CAS  Google Scholar 

  124. Blumethal JA, Matthews K, Fredrikson M, et al. Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein and apolipoprotein concentrations in premenopausal and postmenopausal women. Arteriosclerosis Thrombosis 1991;11:912–7.

    Article  Google Scholar 

  125. Owen JF, Matthews KA, Wing RR, Kuller LH. Physical activity and cardiovascular risk: a cross-sectional study of middle-aged premenopausal women. Prev Med 1990;19:147–51.

    Article  Google Scholar 

  126. Owen JF, Matthews KA, Wing RR, Kuller LH. Can physical activity mitigate the effects of aging in middle-aged women? Circulation 1992;85:1265–70.

    Google Scholar 

  127. Gibbons LW, Blair SN, Cooper KH, Smith M. Association between coronary heart disease risk factors and physical fitness in healthy adult women. Circulation 1983;67(5):977–83.

    Article  PubMed  CAS  Google Scholar 

  128. Moore CE, Hartung GH, Mitchell RF, Kappus CM, Hinderlitter J. The relationship of exercise and diet on high-density lipoprotein cholesterol levels in women. Metabolism 1983;32(2):189–96.

    Article  PubMed  CAS  Google Scholar 

  129. Taylor PA, Ward A. Women, high-density lipoprotein cholesterol, and exercise. Arch Intern Med 1993;153:1178–84.

    Article  PubMed  CAS  Google Scholar 

  130. Cauley JA, Kriska AM, La Porte RE, Sandler RB, Pambianco G. A 2-year randomized exercise trial in older women: effects on HDL-cholesterol. Atherosclerosis 1987;66(3):247–58.

    Article  PubMed  CAS  Google Scholar 

  131. Boyden TW. Effects of exercise training on plasma cholesterol, high-density lipoprotein cholesterol, apolipoprotein Al and sex steroid levels of early menopausal women. In: Eaker ED, Packard B, Wenger N, Clarkson J, Tyroler HA, eds. Coronary heart disease in women. New York: Haymarket Doyma, 1987:160–3.

    Google Scholar 

  132. Dawber TR. The Framingham study: the epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press, 1980:1–257.

    Google Scholar 

  133. Salberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy findings. Arteriosclerosis 1983;3:187–98.

    Article  Google Scholar 

  134. Brown G, Albers JJ, Fisher JD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289–98.

    Article  PubMed  CAS  Google Scholar 

  135. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet 1990;336:129–33.

    Article  PubMed  CAS  Google Scholar 

  136. American Heart Association. Position statement. Dietary guidelines for healthy American adults. Circulation 1986;74:1465A–8A.

    Google Scholar 

  137. Jacques H, Noreau L, Moorjani S. Effects of plasma lipoproteins and endogenous sex hormones of substituting lean white fish for other animal protein sources in diets of postmenopausal women. Am J Clin Nutr 1992; 55:896–901.

    PubMed  CAS  Google Scholar 

  138. Phillips RL. Role of lifestyle and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res 1975;35:3513–22.

    PubMed  CAS  Google Scholar 

  139. Armstrong BK, Brown J, Clarke H, et al. Diet and reproductive hormones: a study of vegetarian and non vegetarian postmenopausal women. J Natl Cancer Inst 1981;67:761–7.

    PubMed  CAS  Google Scholar 

  140. Goldin B, Adlercreutz H, Gorbach S, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986;44:945–53.

    PubMed  CAS  Google Scholar 

  141. Atrens DM. The questionable wisdom of a low-fat diet and cholesterol reduction. Soc Sci Med 1994;39(3):433–47.

    Article  PubMed  CAS  Google Scholar 

  142. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991;87:9–19.

    CAS  Google Scholar 

  143. Verlangieri AJ, Bush M. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992; 11:131–8.

    PubMed  CAS  Google Scholar 

  144. Gaziano JM, Manson JE, Buring JE, Henneckens CH. Dietary antioxidants and cardiovascular disease. Ann NY Acad Sci 1992;669:249–59.

    Article  PubMed  CAS  Google Scholar 

  145. Gaziano JM, Henneckens CH. Vitamin antioxidants and cardiovascular disease. Curr Opin Lipidol 1992;3:291–4.

    Article  CAS  Google Scholar 

  146. Gaziano JM, Manson J, Branch L, et al. Dietary beta-carotene and decreased cardiovascular mortality in an elderly cohort. J Am Coll Cardiol 1991; 19(3):377A.

    Google Scholar 

  147. Rimm EB, Ascherio A, Willett WC, Colditz GA, Giovannucci E, Stampfer M. Dietary antioxidant intake and risk of coronary heart disease among men [abstract]. Am J Epidemiol 1992;136:985–6.

    Google Scholar 

  148. Willet WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317(21):1303–9.

    Article  Google Scholar 

  149. Palmer JR, Rosenberg L, Shapiro S. “Low yield” cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 1989;320(24):1569–73.

    Article  PubMed  CAS  Google Scholar 

  150. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction in women who stop smoking. N Engl J Med 1990;322(4):213–7.

    Article  PubMed  CAS  Google Scholar 

  151. LaCroix AZ. Psychosocial factors and risk of coronary heart disease in women: an epidemiologic perspective. Fertil Steril 1994;62:133S–9S.

    PubMed  CAS  Google Scholar 

  152. Hu Y, Goldman N. Mortality differential by marital status: an international comparison. Demography 1990;27:233–50.

    Article  PubMed  CAS  Google Scholar 

  153. Shumaker SA, Hill DR. Gender differences in social support and physical health. Health Psychol 1991;10:102–11.

    Article  PubMed  CAS  Google Scholar 

  154. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987;101:343–62.

    Article  PubMed  CAS  Google Scholar 

  155. Anda R, Williamson D, Jones D, Macera C, Eaker E, Glassman A, Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993;4:285–94.

    Article  PubMed  CAS  Google Scholar 

  156. Ballinger CB. Psychiatric aspects of the menopause. Br J Psychiatry 1990; 156:773–87.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Daniel E. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nanette Santoro
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA

    Rogerio A. Lobo M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlarg New York, Inc.

About this chapter

Cite this chapter

Stein, D.E., Santoro, N. (1997). Cardiovascular Changes of the Perimenopause and Menopause. In: Lobo, R.A. (eds) Perimenopause. Serono Symposia USA. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2288-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2288-0_16

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7488-9

  • Online ISBN: 978-1-4612-2288-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation